More than 100,000 Americans are currently living with sickle cell disease (SCD), which occurs in approximately one out of every 500 African-American births and one out of every 36,000 Hispanic-American births, according to estimates by the CDC. In 2017 and 2018, two new medicines to treat SCD were approved by the FDA – the first therapies to be marketed in almost two decades.